Kry's country-level telehealth moat
Johannes Schildt & Claes Ruth, CEO and CFO of Kry, on the AI future of telehealth
The real moat in European telehealth is not the video call app, it is the country by country healthcare operating system behind it. To expand beyond one market, a company has to win payer trust, hire and manage local clinicians, plug into prescription and patient data systems, and adapt to different reimbursement rules in each country. Kry is one of the few that turned that work into a repeatable machine across Sweden, the UK, France, and other markets.
-
Kry is not selling a simple software layer. It runs care delivery itself, with its own doctors and nurses, and gets paid by national payers through fee for service visits or citizen based contracts. That makes every new country entry an operational buildout, not just a product launch.
-
Most European telehealth players stayed local because the hard parts are local. Prior research points to French players like Qare and Medadom, UK player Push Doctor, and Sweden's Min Doktor as examples that remained concentrated in home markets, while reimbursement and healthcare governance differ sharply across countries like the UK, Germany, and Sweden.
-
The main exception is Doctolib, but it scaled with a different model. Doctolib spread as scheduling and practice software used by doctors across France, Germany, and Italy, with teleconsultation as a feature. Kry scaled a provider model, which is harder because it carries clinical operations, compliance, and payer relationships market by market.
The next phase is about turning those local builds into shared infrastructure. If Kry keeps reusing one triage flow, one clinician tool stack, and one care model across multiple countries while staying compliant with each market's rules, it can widen the gap between itself and local single country providers, and defend against software led rivals moving into care delivery.